Novartis Catches a ‘Sell.' Goldman Sachs Says the Stock Is Overvalued. - Reportify

Novartis Catches a ‘Sell.' Goldman Sachs Says the Stock Is Overvalued.

Novartis(US:NVS) Barrons·2025-09-12 16:11

Only 20% of analysts tracked by FactSet rate the stock at Buy. ...